id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-N-4590-0002,FDA,FDA-2019-N-4590,"Morton Grove Pharmaceuticals, Inc., et al.; Withdrawal of Approval of 21 
Abbreviated New Drug Applications; Correction",Notice,Correction,2021-07-12T04:00:00Z,2021,7,2021-07-12T04:00:00Z,,2021-07-30T19:08:06Z,2021-14717,0,0,0900006484be41d5
FDA-2019-N-4590-0001,FDA,FDA-2019-N-4590,"Morton Grove Pharmaceuticals, Inc., et al.; Withdrawal of Approval of 21
Abbreviated New Drug Applications",Notice,Withdrawal,2019-12-02T05:00:00Z,2019,12,2019-12-02T05:00:00Z,,2020-05-04T17:35:53Z,2019-25946,0,0,09000064841d66e7